Title : Ribonucleotide reductase R2 gene expression and changes in drug sensitivity and genome stability.

Pub. Date : 1997 Nov 1

PMID : 9354452






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Colonies that developed in the presence of PALA or MTX contained amplifications of the CAD or dihydrofolate reductase genes and exhibited wild-type p53 function as determined in sequence-specific p53 binding activity assays. Methotrexate transformation related protein 53, pseudogene Mus musculus
2 Colonies that developed in the presence of PALA or MTX contained amplifications of the CAD or dihydrofolate reductase genes and exhibited wild-type p53 function as determined in sequence-specific p53 binding activity assays. Methotrexate transformation related protein 53, pseudogene Mus musculus
3 Similarly, mouse 10T1/2 cells that are highly transformed and drug resistant due to alterations in H-ras and a mutant oncogenic form of p53 exhibited significant increases in sensitivity to hydroxyurea, PALA, and MTX when transfected with a vector containing the R2 sequence in antisense orientation and compared to cells containing the same vector without the antisense sequence. Methotrexate transformation related protein 53, pseudogene Mus musculus